WuXi NextCODE Genomics:医療機器:M&Aディール及び事業提携情報

【英語タイトル】WuXi NextCODE Genomics - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10410)・商品コード:DATA904C10410
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:49
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
WuXi NextCODE Genomics USA Inc (WuXi NextCODE), a subsidiary of Wuxi Pharmatech (Cayman) Inc, is a genomic information company that offers competencies in generating, organizing, mining, sharing and applying genomic data. The company develops gene sequence analysis platform and database architecture, which enables clinicians and researchers across the globe to use the power of next-generation sequencing data to better diagnose and treat diseases. WuXi NextCODE’s services comprise genome analysis and interpretation, big data management and storage, custom integration and next generation sequencing. It has operations in Shanghai, Cambridge and Reykjavik. WuXi NextCODE is headquartered in Cambridge, Massachusetts, the US.

WuXi NextCODE Genomics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
WuXi NextCODE Genomics, Medical Equipment Deals By Type, 2012 to YTD 2018 7
WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
WuXi NextCODE Genomics, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
WuXi NextCODE Genomics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
WuXi NextCODE Genomics, Medical Equipment, Deal Details 12
Venture Financing 12
DNAnexus Raises USD58 Million in Equity Financing 12
WuXi NextCODE Raises Additional USD165 Million in Series B Financing 14
WuXi NextCODE Raises USD75 Million in Series B Financing 15
Claritas Genomics Raises USD15 Million in Series B Financing 16
NextCode Health Raises USD15 Million in Series A Financing 18
Partnerships 19
WuXi NextCode Enters into Partnership with Rhythm Pharma 19
AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 20
Genomics England Enters into Contract Agreement with WuXi NextCODE 21
SA1KCGP, WuXi NextCODE and START Enter into Partnership 22
WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 23
WuXi NextCODE Enters into Agreement with Children’s Hospital of Fudan University 24
WuXi NextCODE and DNAnexus Enter into Partnership 25
NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 26
Acquisition 27
WuXi PharmaTech Acquires NextCODE Health for USD65 Million 27
WuXi NextCODE Genomics – Key Competitors 28
WuXi NextCODE Genomics – Key Employees 29
WuXi NextCODE Genomics – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Strategy And Business Planning 31
Jan 09, 2017: AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance 31
Corporate Communications 32
Apr 15, 2018: WuXi NextCODE Appoints Richard Williams As Managing Director And Head Of Oncology Programs 32
Mar 12, 2018: WuXi NextCODE Appoints Rob Brainin As Chief Executive Officer 33
Jan 18, 2018: Wuxi NextCODE Appoints Accomplished Life Sciences Senior Executive Louis Yuan as China General Manager 34
Dec 14, 2017: Dr. Christina Waters Joins Wuxi Nextcode Team to Expand Reach and Impact of the Global Platform for Rare Disease 35
Nov 09, 2017: WuXi NextCODE Appoints Baidu Veteran John Gu to Drive Growth of Genomic Data Platform in China 36
Feb 28, 2017: WuXi NextCODE Appoints Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as COO 37
Feb 20, 2017: WuXi NextCODE Named One of Fast Company’s Top 10 Most Innovative Companies in Biotech for Providing the World’s Leading Platform for Genomic Data 38
Government and Public Interest 39
Feb 28, 2017: China plans leading role in ‘precision medicine’ field 39
Product News 40
Oct 17, 2017: WuXi NextCODE ASHG: Population Genomics, Unleashing Cancer Data, Diagnosing Rare Disease, the Internet of DNA 40
May 15, 2017: WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease and Cancer in Yale Nature study 41
Other Significant Developments 42
Apr 26, 2018: WuXi NextCODE: Introducing an Internet of DNA for Solving Rare Disease 42
Mar 07, 2018: WuXi NextCODE Unveils Genomics Partnership with Google Cloud 43
Feb 12, 2018: 10x Genomics Announces New Partnership Programs 44
Jan 09, 2018: WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity 45
Oct 17, 2017: WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data 46
Feb 08, 2017: Geneformics Selected by WuXi NextCODE to Reduce Data Footprint of Massive, Global Genomics Data 47
Jan 05, 2017: WuXi NextCODE Selected as Genomics Platform for Singapore Precision Medicine Effort 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
WuXi NextCODE Genomics, Medical Equipment, Key Facts 2
WuXi NextCODE Genomics, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
WuXi NextCODE Genomics, Medical Equipment Deals By Type, 2012 to YTD 2018 7
WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
WuXi NextCODE Genomics, Deals By Market, 2012 to YTD 2018 9
WuXi NextCODE Genomics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DNAnexus Raises USD58 Million in Equity Financing 12
WuXi NextCODE Raises Additional USD165 Million in Series B Financing 14
WuXi NextCODE Raises USD75 Million in Series B Financing 15
Claritas Genomics Raises USD15 Million in Series B Financing 16
NextCode Health Raises USD15 Million in Series A Financing 18
WuXi NextCode Enters into Partnership with Rhythm Pharma 19
AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 20
Genomics England Enters into Contract Agreement with WuXi NextCODE 21
SA1KCGP, WuXi NextCODE and START Enter into Partnership 22
WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 23
WuXi NextCODE Enters into Agreement with Children's Hospital of Fudan University 24
WuXi NextCODE and DNAnexus Enter into Partnership 25
NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 26
WuXi PharmaTech Acquires NextCODE Health for USD65 Million 27
WuXi NextCODE Genomics, Key Competitors 28
WuXi NextCODE Genomics, Key Employees 29
WuXi NextCODE Genomics, Other Locations 30

List of Figures
WuXi NextCODE Genomics, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
WuXi NextCODE Genomics, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
WuXi NextCODE Genomics, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[WuXi NextCODE Genomics:医療機器:M&Aディール及び事業提携情報] (コード:DATA904C10410)販売に関する免責事項を必ずご確認ください。
★調査レポート[WuXi NextCODE Genomics:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆